Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$443,204,724
+$64,247,539 QoQ
Shares Held
1,761,265
+1.1% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#89
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $3,027,251,343 across 9 Drug Manufacturers - General names. ABBV ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
640,845 | $768,648,782 | |
| 2 | JNJ |
Johnson & Johnson
|
2,438,843 | $619,392,956 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,761,265 | $443,204,724 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,816,256 | $361,888,896 | |
| 5 | AZN |
Astrazeneca PLC
|
1,526,363 | $289,428,952 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,648,030 | $208,212,110 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,765,830 | $159,367,124 | |
| 8 | PFE |
Pfizer Inc
|
6,258,004 | $150,692,736 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,204,724 | 1,761,265 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $378,957,185 | 1,742,412 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $393,957,431 | 1,724,178 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $446,132,659 | 1,926,806 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $339,822,699 | 1,830,744 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $395,133,767 | 1,885,900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $368,015,632 | 2,070,994 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $400,413,211 | 2,027,614 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $340,958,604 | 1,987,865 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $341,557,502 | 1,875,659 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $289,115,594 | 1,865,623 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $217,405,051 | 1,458,507 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $191,900,113 | 1,424,331 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $230,853,181 | 1,448,536 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $224,514,429 | 1,389,236 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $200,667,033 | 1,495,172 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $229,711,052 | 1,499,811 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $246,694,458 | 1,521,772 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $204,561,236 | 1,510,792 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $164,241,998 | 1,522,592 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $172,939,007 | 1,535,325 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $162,402,289 | 1,500,668 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $203,641,464 | 1,900,527 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $165,128,168 | 1,885,240 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $179,687,168 | 1,830,181 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $112,254,612 | 1,473,351 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||